What does Hilo do?
Hilo provides cutting-edge cuffless blood pressure monitoring products, using optical signals and advanced machine learning to generate comprehensive blood pressure reports for both individuals and healthcare professionals.
How much did they raise?
The company raised $42M in a Series B funding round, led by Earlybird Health and Wellington Partners, with participation from KFund, naturalX Health Ventures, redalpine, Khosla Ventures, Molten Ventures, TransLink Capital, and Verve Ventures, bringing total financing to over $100M.
What are their plans for the money?
Hilo plans to use the funds to accelerate product innovation, expand into new markets, and enhance its blood pressure intelligence platform to support enterprise-level applications, positioning it for further growth in healthcare technology.
What have they achieved so far?
Demonstrating significant progress, Hilo has trained its model on data from more than 120,000 users, contributed to over 120 peer-reviewed publications, and secured more than 35 patents, showcasing its strong expertise in biomedical signal processing.
